Quick Takeaways
- This page summarizes Jon Snodgres's Form 4 filing for REPLIGEN CORP (RGEN).
- 4 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 06 Mar 2023, 16:33.
Jon Snodgres - 02 Mar 2023 Form 4 Insider Report for REPLIGEN CORP (RGEN)
- Signature
- /s/ Kimberly Brown (Attorney in Fact)
- Issuer symbol
- RGEN
- Transactions as of
- 02 Mar 2023
- Net transactions value
- -$690,712
- Form type
- 4
- Filing time
- 06 Mar 2023, 16:33:56 UTC
- Previous filing
- 01 Mar 2023
- Next filing
- 16 May 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Jon Snodgres filed Form 4 for REPLIGEN CORP (RGEN) on 06 Mar 2023."
What Changed
- Previous filing in this sequence was filed on 01 Mar 2023.
- Current net transaction value: -$690,712.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Common Stock | Award | $0 | +4,848 | +17% | $0.000000 | 32,970 | 02 Mar 2023 | Direct | F1 |
| transaction | RGEN | Common Stock | Award | $0 | +8,795 | +27% | $0.000000 | 41,765 | 03 Mar 2023 | Direct | F2 |
| transaction | RGEN | Common Stock | Tax liability | $690,712 | -3,674 | -8.8% | $188.00 | 38,091 | 03 Mar 2023 | Direct | F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Stock Option (Right to Buy) | Award | $0 | +5,019 | $0.000000 | 5,019 | 02 Mar 2023 | Common Stock | 5,019 | $180.48 | Direct | F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Mr. Snodgres was awarded 4,848 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| F2 | Represents 625 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022, and 8,170 shares issued pursuant to a PSU award granted to the Issuer on February 27, 2020. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU awards. |
| F3 | Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. |
| F4 | One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025, and March 2, 2026. |